Ireland· IE-PA-EU/1/14/956/014-0016
Trulicity 4.5 mg Solution for injection
A blood glucose lowering drugs, excl. insulins product containing dulaglutide, registered in Ireland by Eli Lilly Nederland B.V..
Checked against HPRA (Ireland) on
Informational only — not a medical device.
The record
At a glance
HPRA (Ireland)- Active substance
- Dulaglutide
- Manufacturer
- Eli Lilly Nederland B.V.
- Country
- Ireland (IE)
- ATC code
- A10B
- ATC class
- BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/14/956/014-0016
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dulaglutide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceTRULICITY 4,5 mg, solution injectable en stylo pré-rempliELI LILLY NEDERLAND (PAY-BAS)
- NetherlandsTrulicity 4,5 mg oplossing voor injectie in voorgevulde penEli Lilly Nederland B.V.
- United StatesTrulicityA-S Medication Solutions
- CzechiaTRULICITYEli Lilly Nederland B.V., Utrecht
- FinlandTrulicityEli Lilly Nederland B.V.
- NorwayTrulicityEli Lilly and Company Limited
- BelgiumTrulicity 0.75 mgEli Lilly Nederland
- United KingdomTrulicity 0.75mg/0.5ml solution for injection pre-filled pensPharmaram Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Trulicity
- Liechtenstein · Trulicity
- Norway · Trulicity
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5ad9380e-4034-40f4-acb1-76f4eab10925 GET /v1/drugs/5ad9380e-4034-40f4-acb1-76f4eab10925?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled pen",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"A10B"
],
"strength": null,
"pa_number": "EU/1/14/956/014-0016",
"substances": [
"Dulaglutide"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "21/11/2014",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about dulaglutide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.